The medical device purification system developed by Huakang Century. [Photo provided to en.whkfq.gov.cn]

An application for the initial public offering (IPO) of Wuhan Huakang Century Medical Co, a company based in the East Lake High-tech Development Zone (also known as Optics Valley of China), received official approval on Nov 5.

Its application means that the firm is likely to become the fifth listed enterprise from OVC this year, after Cubic Sensor and Instrument Co, Wuhan Citms High-technology Co, Kindstar Globalgene Technology Inc, and Wuhan KOTEI Informatics Co.

Huakang Century is likely to raise 440 million yuan ($68.64 million) from its IPO, which will be used to upgrade research programs, and establish a sales and operation center. 

Founded in 2008, Huakang Century is a modern medical device purification system and service provider, committed to reducing infections and providing clean, safe and intelligent conditions for hospitals, with its main business covering the research, design, sales, installment and maintenance of medical purification systems.

The company has served Huoshenshan Hospital, Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, Renmin Hospital of Wuhan University (Hubei General Hospital), Zhongnan Hospital of Wuhan University, and other renowned hospitals in Anhui and Guangdong provinces.

By the end of June, Huakang Century held 102 applied patents, nine industrial design patents, 21 software copyrights and one right of layout-designs of integrated circuits.